グループBの慢性閉塞性肺疾患の推定における入院患者による吸入器使用の評価
Noah S Ball1, Eric M Kinney1, Erin McMahan1
1WVU Medicine - WVU Hospitals; Morgantown, WV.
Journal of the American Pharmacists Association : JAPhA
|September 5, 2025
まとめ
B群の慢性閉塞性肺疾患 (COPD) の患者では,処方薬の制限により,不適切な使用が一般的です. これは肺炎のような有害事象のリスクを高め,インハラータへのアクセスを改善する必要性を強調しています.
科学分野:
- 肺医学
- 薬学経済学
- 臨床薬局
背景:
- 長期作用のマスカリン抗体 (LAMA) と長期作用のベータアゴニスト (LABA) の組み合わせ治療は,グループBの慢性閉塞性肺疾患 (COPD) の治療に推奨されます.
- 吸入用コルチコステロイド (ICS) は,この集団において,利益を与えず,リスクを増加させる可能性があります.
- 入院薬剤の制限は,不適切なICS使用と有害事象につながる可能性があります.
研究 の 目的:
- グループBのCOPD患者に対して,入院中のICS投与の適切性を評価する.
- このコホートにおけるICSに関連する有害事象の発生率を決定する.
主な方法:
- グループBのCOPDと推定される患者100人を対象とした遡及コホート研究.
- 2022年7月から2023年9月までの電子医療記録 (EPIC) データを活用した.
- 以前のICSの遵守,最近の悪化,喘息,または薬の調整がない患者を除外した.
主要な成果:
- 14%の患者はGOLDのガイドラインに反してICS治療を受けた.
- これらの患者の14%がICS関連肺炎を発症した可能性がある.
- ICSの不適切な処方には,吸入器の利用可能性が影響する.
結論:
- 入院時の処方箋の制限は,グループBのCOPDにおける不適切なICS使用に寄与する可能性があります.
- LAMA/LABA吸入器が利用できない場合,ICSの使用を促す可能性があります.
- COPDの管理を最適化するために,処方箋の制限に対処することが重要です.
関連する概念動画
01:23Inhaled Medications
387
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
387
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
300
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
300
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.2K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.2K